Treatment FAQs

1. What should I know before the Curawave procedure?
Read More

You should let your doctor know if you are allergic to certain medications or contrast agents, and if you have metallic implants or medical patches. Your doctor need to know if you should avoid any type of materials used during the procedure. You and your doctor will also decide what type of sedation works best for you. Most doctors use conscious sedation, which means you are awake during the procedure, but you may feel groggy.

2. What should I discuss with my physician before undergoing the Curawave treatment?
Read More

  • Your personal health history, including any allergies you may have
  • Your family’s health history, including family cancer history
  • Any recent illnesses
  • Medicines, include both prescription, over-the-counter and herbal medicines or dietary supplements
  • Any implants and/or medical patches
  • Recent activities, including air travel
  • Your level of normal physical activity
  • Previous MR or CT imaging studies

3. How do I know if I am eligible for treatment?
Read More

Your doctor is the best person to ask about this. Your doctor will be able to tell you if you are a suitable candidate for the Curawave treatment. In general, people who cannot go into an MRI will not be able to go through the treatment – this includes patients with metallic implants, patients who are claustrophobic, and patients who are allergic to contrast agents – a dye used to see blood vessels during MR imaging.

4. What risks and complications are associated with the Curawave treatment?
Read More

Overall, when used appropriately, Curawave is a safe procedure for treating symptomatic fibroids with minimal risk. Infrequent complications that have been reported following Curawave are listed below. You should talk to your doctor if you experience any of the following risks:

  • Dizziness
  • Back or leg pain that persists for a few days
  • Mild skin burns (rarely)
  • Allergic reaction to contrast media or medications
  • Abdominal pain/cramping, nausea and/or fever
    Urinary tract infection
  • The treatment may be successful in reducing the symptoms from the fibroids that are treated, but at a later time, more fibroids may become symptomatic, requiring additional treatments. This is true for all fibroid treatments, except hysterectomy
  • There is a chance that the treatment may not be successful and you may require an alternative treatment therapy to improve your symptoms

Any questions concerning risks and complications of the procedure, should be discussed with your doctor.

5. After the procedure, what will happen?
Read More

Curawave is performed as an outpatient procedure that takes between 3-4 hours. Following the treatment you will rest for an additional 1-2 hours until the sedation wears off.  After that, you will be released with instructions from your doctor.

6. What should I watch out for post procedure?
Read More

Occasionally women may experience some cramping, similar to menstrual period cramping or shoulder/back pain from lying on the treatment bed. Prior to your release from the facility, you should be aware of who to contact in an emergency.  You should reach out to this contact if you experience foul-smelling vaginal discharge that increases over time and lasts more than 24 hours, fever, or pelvic pain.

7. Who will provide my post procedure care following the treatment?
Read More

It is important that you discuss with your doctor ahead of time who will handle your follow-up care. Arrange follow-up phone calls and/or office visits for after the procedure.

8. How soon after the treatment will my symptoms be gone?
Read More

Most patients find relief in their fibroid related symptoms within the first 3 months. In a previous clinical study conducted by INSIGHTEC, 109 women who had symptomatic uterine fibroids were treated 7 medical centres around the world. The study treatment was restricted to no more than 33% of the fibroid volume. Under these specific treatment conditions, after 6 months, 70.6% percent of women had experienced an improvement in their symptoms. Of the women who continued in the study at the 12 month time point, 50.4% continued to experience an improvement in their symptoms.

Font Resize